• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians

tetano

Editor, Senior Moderator
Immunol Cell Biol. 2015 Oct 23. doi: 10.1038/icb.2015.93. [Epub ahead of print]
[h=1]Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians.[/h] Bridie Clemens E[SUP]1[/SUP], Grant EJ[SUP]1[/SUP], Wang Z[SUP]1[/SUP], Gras S[SUP]2,[/SUP][SUP]3[/SUP], Tipping P[SUP]4[/SUP], Rossjohn J[SUP]2,[/SUP][SUP]3,[/SUP][SUP]5[/SUP], Miller A[SUP]6[/SUP], Tong SY[SUP]4[/SUP], Kedzierska K[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Indigenous populations, including Indigenous Australians, are highly susceptible to severe influenza disease and the underlying mechanisms are unknown. We studied immune and genetic factors that could predicate severe influenza disease in Indigenous Australians enrolled in the LIFT study: Looking into InFluenza T cell immunity. To examine CD8[SUP]+[/SUP] T cell immunity, we characterised human leukocyte antigen (HLA) profiles. HLA typing confirmed previous studies showing predominant usage of HLA-A*02:01, 11:01, 24:02, 34:01 and HLA-B*13:01, 15:21, 40:01/02, 56:01/02 in Indigenous Australians. We identified two new HLA alleles (HLA-A*02:new and HLA-B*56:new). Modeling suggests that variations within HLA-A*02:new (but not HLA-B56:new) could affect peptide binding. There is a relative lack of known influenza epitopes for the majority of these HLAs, with the exception of a universal HLA-A*02:01-M1[SUB]58[/SUB] epitope and proposed epitopes presented by HLA-A*11:01/HLA-A*24:02. To dissect universal CD8[SUP]+[/SUP] T cell responses, we analysed the magnitude, function and T cell receptor (TCR) clonality of HLA-A*02:01-M1[SUB]58[/SUB][SUP]+[/SUP]CD8[SUP]+[/SUP] T cells. We found comparable IFN-γ, TNF and CD107a and TCRαβ characteristics in Indigenous and non-Indigenous Australians, suggesting that the ~15% of Indigenous people that express HLA-A*02:01 have universal influenza-specific CD8[SUP]+[/SUP] T cell immunity. Furthermore, the frequency of an influenza host risk factor, IFITM3-C/C, was comparable between Indigenous Australians and Europeans, suggesting that expression of this allele does not explain increased disease severity at a population level. Our study indicates a need to identify novel influenza-specific CD8[SUP]+[/SUP] T cell epitopes restricted by HLA-A and HLA-B alleles prevalent in Indigenous populations for the rational design of universal T cell vaccines.Immunology and Cell Biology accepted article preview online, 23 October 2015. doi:10.1038/icb.2015.93.


PMID: 26493179 [PubMed - as supplied by publisher]
 
Back
Top Bottom